GMVCX
Price
$15.68
Change
+$0.03 (+0.19%)
Updated
Oct 17 closing price
Net Assets
140.3M
VIMAX
Price
$358.27
Change
+$0.63 (+0.18%)
Updated
Oct 17 closing price
Net Assets
201.28B
Interact to see
Advertisement

GMVCX vs VIMAX

Header iconGMVCX vs VIMAX Comparison
Open Charts GMVCX vs VIMAXBanner chart's image
Goldman Sachs Small/Mid Cap Equity C
Price$15.68
Change+$0.03 (+0.19%)
VolumeN/A
Net Assets140.3M
Vanguard Mid Cap Index Admiral
Price$358.27
Change+$0.63 (+0.18%)
VolumeN/A
Net Assets201.28B
GMVCX vs VIMAX Comparison Chart in %
View a ticker or compare two or three
VS
GMVCX vs. VIMAX commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMVCX is a Hold and VIMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMAX has more cash in the bank: 201B vs. GMVCX (140M). VIMAX pays higher dividends than GMVCX: VIMAX (1.48) vs GMVCX (0.08). GMVCX was incepted earlier than VIMAX: GMVCX (12 years) vs VIMAX (24 years). GMVCX (2.19) is less costly to investors than VIMAX (0.05). GMVCX is a more actively managed with annual turnover of: 67.00 vs. VIMAX (16.00). GMVCX has a lower initial minimum investment than VIMAX: GMVCX (1000) vs VIMAX (3000). VIMAX annual gain was more profitable for investors over the last year : 7.58 vs. GMVCX (-3.96). VIMAX return over 5 years is better than : 57.32 vs. GMVCX (36.22).
GMVCXVIMAXGMVCX / VIMAX
Total Expense Ratio1.930.053,860%
Annual Report Gross Expense Ratio2.190.054,380%
Fund Existence12 years24 years-
Gain YTD0.0649.7071%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets140M201B0%
Annual Yield % from dividends0.081.485%
Returns for 1 year-3.967.58-52%
Returns for 3 years14.3749.7029%
Returns for 5 years36.2257.3263%
Returns for 10 years49.89140.9335%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NVX1.980.02
+1.02%
NOVONIX Limited
CXM7.620.05
+0.66%
Sprinklr
ABVC2.92N/A
N/A
ABVC BioPharma
ATIIU10.59N/A
N/A
Archimedes Tech SPAC Partners II Co
MDGL438.90-3.23
-0.73%
Madrigal Pharmaceuticals